語系:
繁體中文
English
說明(常見問題)
圖資館首頁
登入
回首頁
切換:
標籤
|
MARC模式
|
ISBD
Polymyxin antibioticsfrom laboratory...
~
Kaye, Keith S.
Polymyxin antibioticsfrom laboratory bench to bedside /
紀錄類型:
書目-電子資源 : Monograph/item
正題名/作者:
Polymyxin antibioticsedited by Jian Li, Roger L. Nation, Keith S. Kaye.
其他題名:
from laboratory bench to bedside /
其他作者:
Li, Jian.
出版者:
Cham :Springer International Publishing :2019.
面頁冊數:
viii, 366 p. :ill. (some col.), digital ;24 cm.
Contained By:
Springer eBooks
標題:
Polymyxin.
電子資源:
https://doi.org/10.1007/978-3-030-16373-0
ISBN:
9783030163730$q(electronic bk.)
Polymyxin antibioticsfrom laboratory bench to bedside /
Polymyxin antibiotics
from laboratory bench to bedside /[electronic resource] :edited by Jian Li, Roger L. Nation, Keith S. Kaye. - Cham :Springer International Publishing :2019. - viii, 366 p. :ill. (some col.), digital ;24 cm. - Advances in experimental medicine and biology,v.11450065-2598 ;. - Advances in experimental medicine and biology ;946..
Overview -- Multidrug resistant Gram-negative pathogens: the urgent need for 'old' polymyxins -- Discovery, antibacterial spectrum and chemistry -- Mechanisms of antibacterial activity -- Mechanisms of resistance -- Bioanalysis and stability of polymyxins -- In vitro pharmacodynamics and PK/PD in animals -- Antibacterial susceptibility breakpoints -- Labeling of parenteral products of colistin methanesulfonate -- Meta-analysis of polymyxin use in patients -- Clinical use of colistin -- Clinical use of polymyxin B -- Pharmacokinetics, pharmacodynamics, toxicodynamics and dosing recommendations -- Rational combinations with other antibiotics -- Toxicities in patients: management and mechanisms -- Antiendotoxin effect -- Discovery of novel polymyxin-like antibiotics -- Conclusion.
This volume is the first-ever complete treatise on polymyxins and presents the most comprehensive and up-to-date reviews of all major research and clinical topics from chemistry, microbiology, pharmacology, clinical use, to drug discovery. All chapters were written by internationally leading researchers and clinicians in the field. It is our wish that readers discover the importance of polymyxin structure in relation to the mechanisms of activity, resistance and toxicity. We emphasized that reliable analytic methods for polymyxins are critical when investigating their pharmacokinetics (PK) and pharmacodynamics (PD) The complicated dose definitions and different pharmacopoeial standards have already compromised the safe use of polymyxins in patients. Therefore, informed by the latest pharmacological information, scientifically-based dosing recommendations have been proposed for intravenous polymyxins. Considering the PK/PD limitations and potential development of resistance, polymyxin combinations are encouraged; however, the current literature has not shown definite microbiological benefits, possibly because most clinical studies to date overlooked key PK/PD principles. Nephrotoxicity is the major dose-limiting factor and it is imperative to elucidate the mechanisms and develop novel approaches to minimize polymyxin-associated toxicities. In addition, the anti-endotoxin effect of polymyxins supports their clinical use to treat Gram-negative sepsis. Fortunately, the discovery of new-generation polymyxins with wider therapeutic windows has benefited from the latest achievements in polymyxin research. This book provides extensive pharmacological information on polymyxins to infectious diseases clinicians, pharmacists, clinical microbiologists, antimicrobial pharmacologists, and pharmaceutical scientists, and is an essential read for those who aim to develop novel polymyxins and improve their clinical use as a last-line defense against Gram-negative 'superbugs'.
ISBN: 9783030163730$q(electronic bk.)
Standard No.: 10.1007/978-3-030-16373-0doiSubjects--Topical Terms:
849207
Polymyxin.
LC Class. No.: RM267 / .P659 2019
Dewey Class. No.: 615.7922
Polymyxin antibioticsfrom laboratory bench to bedside /
LDR
:03885nmm a2200337 a 4500
001
563572
003
DE-He213
005
20191126161411.0
006
m d
007
cr nn 008maaau
008
200311s2019 gw s 0 eng d
020
$a
9783030163730$q(electronic bk.)
020
$a
9783030163716$q(paper)
024
7
$a
10.1007/978-3-030-16373-0
$2
doi
035
$a
978-3-030-16373-0
040
$a
GP
$c
GP
041
0
$a
eng
050
4
$a
RM267
$b
.P659 2019
072
7
$a
PSGD
$2
bicssc
072
7
$a
SCI006000
$2
bisacsh
072
7
$a
PSG
$2
thema
082
0 4
$a
615.7922
$2
23
090
$a
RM267
$b
.P783 2019
245
0 0
$a
Polymyxin antibiotics
$h
[electronic resource] :
$b
from laboratory bench to bedside /
$c
edited by Jian Li, Roger L. Nation, Keith S. Kaye.
260
$a
Cham :
$b
Springer International Publishing :
$b
Imprint: Springer,
$c
2019.
300
$a
viii, 366 p. :
$b
ill. (some col.), digital ;
$c
24 cm.
490
1
$a
Advances in experimental medicine and biology,
$x
0065-2598 ;
$v
v.1145
505
0
$a
Overview -- Multidrug resistant Gram-negative pathogens: the urgent need for 'old' polymyxins -- Discovery, antibacterial spectrum and chemistry -- Mechanisms of antibacterial activity -- Mechanisms of resistance -- Bioanalysis and stability of polymyxins -- In vitro pharmacodynamics and PK/PD in animals -- Antibacterial susceptibility breakpoints -- Labeling of parenteral products of colistin methanesulfonate -- Meta-analysis of polymyxin use in patients -- Clinical use of colistin -- Clinical use of polymyxin B -- Pharmacokinetics, pharmacodynamics, toxicodynamics and dosing recommendations -- Rational combinations with other antibiotics -- Toxicities in patients: management and mechanisms -- Antiendotoxin effect -- Discovery of novel polymyxin-like antibiotics -- Conclusion.
520
$a
This volume is the first-ever complete treatise on polymyxins and presents the most comprehensive and up-to-date reviews of all major research and clinical topics from chemistry, microbiology, pharmacology, clinical use, to drug discovery. All chapters were written by internationally leading researchers and clinicians in the field. It is our wish that readers discover the importance of polymyxin structure in relation to the mechanisms of activity, resistance and toxicity. We emphasized that reliable analytic methods for polymyxins are critical when investigating their pharmacokinetics (PK) and pharmacodynamics (PD) The complicated dose definitions and different pharmacopoeial standards have already compromised the safe use of polymyxins in patients. Therefore, informed by the latest pharmacological information, scientifically-based dosing recommendations have been proposed for intravenous polymyxins. Considering the PK/PD limitations and potential development of resistance, polymyxin combinations are encouraged; however, the current literature has not shown definite microbiological benefits, possibly because most clinical studies to date overlooked key PK/PD principles. Nephrotoxicity is the major dose-limiting factor and it is imperative to elucidate the mechanisms and develop novel approaches to minimize polymyxin-associated toxicities. In addition, the anti-endotoxin effect of polymyxins supports their clinical use to treat Gram-negative sepsis. Fortunately, the discovery of new-generation polymyxins with wider therapeutic windows has benefited from the latest achievements in polymyxin research. This book provides extensive pharmacological information on polymyxins to infectious diseases clinicians, pharmacists, clinical microbiologists, antimicrobial pharmacologists, and pharmaceutical scientists, and is an essential read for those who aim to develop novel polymyxins and improve their clinical use as a last-line defense against Gram-negative 'superbugs'.
650
0
$a
Polymyxin.
$3
849207
650
0
$a
Antibiotics.
$3
220398
650
1 4
$a
Bacteriology.
$3
273947
650
2 4
$a
Pharmacotherapy.
$3
615025
650
2 4
$a
Drug Resistance.
$3
338425
700
1
$a
Li, Jian.
$3
246220
700
1
$a
Nation, Roger L.
$3
849205
700
1
$a
Kaye, Keith S.
$3
849206
710
2
$a
SpringerLink (Online service)
$3
273601
773
0
$t
Springer eBooks
830
0
$a
Advances in experimental medicine and biology ;
$v
946.
$3
557559
856
4 0
$u
https://doi.org/10.1007/978-3-030-16373-0
950
$a
Biomedical and Life Sciences (Springer-11642)
筆 0 讀者評論
全部
電子館藏
館藏
1 筆 • 頁數 1 •
1
條碼號
館藏地
館藏流通類別
資料類型
索書號
使用類型
借閱狀態
預約狀態
備註欄
附件
000000174876
電子館藏
1圖書
電子書
EB RM267 .P783 2019 2019
一般使用(Normal)
在架
0
1 筆 • 頁數 1 •
1
多媒體
多媒體檔案
https://doi.org/10.1007/978-3-030-16373-0
評論
新增評論
分享你的心得
Export
取書館別
處理中
...
變更密碼
登入